Health & Life Sciences

Italian Health & Life Science Market Overview

Italy ranks among the world's leading pharmaceutical centers, offering a big investment opportunity for the Danish life science sector. With a population of about 59 million, Italy presents significant market potential for healthcare products, services, and solutions. The country's universal healthcare system is regarded as one of the best globally, sharing many qualities with the Danish system, and ensuring access to quality healthcare for all citizens.

The Italian life science sector is a key contributor to the national economy. As the second-largest pharmaceutical producer in Europe and the tenth in the world, the industry accounts for a significant portion of Italy's exports. Approximately two-thirds of the sector focuses on pharmaceuticals, while the remaining third includes medical devices and biotech.

Need for Investments and Modernization

Italy faces challenges due to its aging population and the prevalence of chronic conditions, necessitating increased resources and funding. This demographic shift creates opportunities for investment in health technologies, solutions, and services that cater to these needs.

To ensure the sustainability of the healthcare system and attract investments, policies are being implemented under the National Recovery and Resilience Plan (NRRP). With EUR 15,6 billion allocated, Italy aims to modernize its healthcare system and enhance technological and digital solutions to improve care access.

Contact the Health & Life Science team

For detailed opportunities and assistance in the Italian market, our team, with over 25 years of experience in the healthcare sector, supports Danish life science companies to drive growth and innovation. Contact us to learn more.